Moreover, iNOS upregulation impairs endothelial NOS (eNOS)-derived nitric oxide formation causing endothelial dysfunction [35] and also increases arginase activity decreasing nitric oxide bioavailability [36]. This evidence concerns the gene NOS2 and endothelial dysfunction.